News About: Pharm. Affairs
Competition to attract pharma distribution companies in online drug market
Online drug shopping malls operated by affiliates of pharmaceutical company are trying hard to make partnership with pharmaceutical distribution companies.
According to the industry concerned, it was told online drug...
8 of 10 products approved this year were ‘ETC’
It was observed 8 of 10 pharmaceutical products approved this year were ETC drugs.
According to the Ministry of Food and Drug Safety’s Online Pharmaceutical Library, there were the total 2,779 products approved betwe...
“Obligation of generic name prescription is proven in effectiveness and strengths”
When it came to the Korean Medical Association’s opposition to the obligation of prescription with generic name on the 23rd, the Korean Pharmaceutical Association’s 16 regional associations council announced “As an or...
Undecided direction on Korean distribution license for Gilead’s Sovaldi and Harvoni
It is hard to predict where the Korean distribution license of ‘Sovaldi’ and ‘Harvoni,’ Gilead Sciences’ chronic hepatitis C treatments that have drawn interests of both pharmaceutical and distribution industries as l...
Rapid growth of Dong Wha Pharm’s Each to stand the top in toothpaste-type gum treatment market
The Dong Wha Pharm’s paste-type gum therapy ‘Each’ has made a rapid growth.
According to the company, after recording KRW 3.7 billion sales after the release in 2011 with a concept called ‘gum treatment and tooth bru...
Alteogen completes clinical trial of ‘Herceptin’ biosimilar
Alteogen announced the Phase 1 clinical trial of a biosimilar of Herceptin, a breast cancer therapy, which has been conducted in Canada since February, was successfully completed.
Alteogen has carried out the Phase 1...
Hanmi, “We have no problem supplying the only influenza substitute Hanmi Flu”While the crisis occurred to supply foreign products as the flu virus spreads across the nation, Hanmi Pharm, a company owning the only substitute, announced to put the best eff...
|
1,112 products approved by bioequivalence test this year
The number of pharmaceutical products approved by bioequivalence test this year was aggregated at 1,112 products.
According to the Ministry of Food and Drug Safety, the collective number of products approved by bioeq...
Hanmi Flu outnumbers Tamiflu in flu medicine market
The market share of ‘Hanmi Flu,’ a Korean influenza treatment, exceeded 50%.
According to Hanmi Pharm on the 21st, after the flu watch was alerted, its prescriptions were rapidly increased, which made the market shar...
Yuan & Boehringer’s agreement renewal on major products
On the 20th, Yuhan Corporation(CEO Jung-Hee Lee) announced a strategic agreement for Korean marketing, sales and distribution of Boehringer Ingelheim’s major products with Boehringer Ingelheim(CEO Ki-Hwan Park).
Unde...
